Navigation Links
Metabolex to Present Data on Arhalofenate, a Potential Novel Treatment for Gout, at the 2011 ACR/ARHP Annual Scientific Meeting
Date:11/1/2011

HAYWARD, Calif., Nov. 1, 2011 /PRNewswire/ -- Metabolex, Inc., a biopharmaceutical company focused on the discovery and development of proprietary new medicines for the treatment of metabolic diseases, today announced that it will be presenting data on arhalofenate, a potential best-in-class treatment for gout, at the 2011 ACR/AHP Annual Scientific Meeting on Wednesday, November 9, 2011 in Chicago, IL.  The presentation will describe the results of a pooled analysis of four Phase 2 studies in patients with type 2 diabetes, a subset of which exhibited hyperuricemia. The analysis shows that the patients experienced statistically and clinically significant reductions in serum uric acid that were fully retained in patients with mild-to-moderate renal insufficiency.  

Presentation Title: "Arhalofenate, a Potential Novel Treatment for Hyperuricemia, with or without Metabolic Co-Morbidities, in Patients with Gout: Meta-Analysis of Urate Lowering in Four Phase 2 Studies in Type 2 Diabetes"

Session Title: Metabolic and Crystal Arthropathies II: Concurrent Session on the Anti-Gout Medications – Dosing, Adverse Effects, and Economic Burden

Date/Time:  Wednesday, November 9, 2011 from 10:15 AM - 10:30 AM CST

Location: McCormick Place Convention Center: W 474 A

About Hyperuricemia and Gout

Gout is a chronic, progressive rheumatic disease, caused by an inflammatory response to uric acid crystals deposited in joints and soft tissues as a result of excess uric acid in the blood (hyperuricemia). Elevated sUA levels cause urate crystals for form in joints triggering acute arthritic flares, chronic destructive arthropathy and formation of tophi.  According to the NHANES (2007-2008) study, the incidence of hyperuricemia in the US is over 45 million and over 8 million have progressed to a gout diagnosis.  

About Metabolex

Metabolex is a privately
'/>"/>

SOURCE Metabolex, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Metabolex Begins Phase 2 Trial of MBX-8025 for Treatment of Dyslipidemia
2. Metabolex Initiates Phase 1 Trial of MBX-2982
3. Metabolex Completes Patient Enrollment in Phase 2 Trial of MBX-8025 for Treatment of Dyslipidemia
4. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
5. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
6. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
7. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
8. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
9. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
10. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
11. Iomai Announces Data from Phase 2 Field Study of Travelers Diarrhea Vaccine Accepted for Presentation at ICAAC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... August 27, 2014 According ... Products (Dental Radiology, CAD/CAM, Dental Chairs, Dental Lasers), Current Trends, ... MarketsandMarkets, the global Dental Equipment Market is expected to ... in 2014, growing at a CAGR of 5.7% ... market data tables and 61 figures spread through ...
(Date:8/27/2014)... , Aug. 27, 2014 ISPE ... that it has released a preview of its ... pharmaceutical industry avoid drug shortages and maintain a robust ... The Plan, a first for the industry, ... biopharmaceutical industry members and describes how industry can best ...
(Date:8/27/2014)... New York , August 27, 2014 ... United States  Laparoscopes Market Outlook to ... 2020", provides key market data on the United ... millions of US dollars, volume (in units) and average ... (Rigid Tip Video Laparoscopes and Flexible Tip Video Laparoscopes), ...
Breaking Medicine Technology:Dental Equipment Market Worth $7,138.9 Million by 2019 2Dental Equipment Market Worth $7,138.9 Million by 2019 3ISPE Releases First Look at its Plan to Prevent Drug Shortages 2ISPE Releases First Look at its Plan to Prevent Drug Shortages 3ISPE Releases First Look at its Plan to Prevent Drug Shortages 4United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 2United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 3United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 4United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 5
... 11, 2011 Rapid Fire Marketing (Pink ... wholly owned subsidiary, Medical Cannabis Management (MCM), ... cultivation and growing of medical cannabis. Management of MCM ... will significantly increase revenue and earnings through 2011 and ...
... April 11, 2011 ConvaTec, a world-leading developer ... and hospital care, today announced that Holy Family ... which offers a line of products designed to ... therapy (NPWT). ConvaTec Negative Pressure features the Engenex ...
Cached Medicine Technology:Rapid Fire Marketing: Medical Cannabis Management Cleared for Medical Cannabis Cultivation 2Holy Family Medical Center Selects ConvaTec Negative Pressure for Wound Care 2Holy Family Medical Center Selects ConvaTec Negative Pressure for Wound Care 3
(Date:8/27/2014)... (PRWEB) August 27, 2014 For nearly ... performances by the beloved mantra singers Deva Premal & ... Following the release of their latest album in May, ... down in twenty-two countries around the globe, including Russia, ... Argentina and across Europe. With a new album and ...
(Date:8/27/2014)... positive hospital blood culture samples are discarded every day ... skin germs instead of specific disease-causing bacteria. , ... clinicians may be able to use the resistance profiles ... patients with antibiotics appropriate to their ailment, Tel Aviv ... Alon of TAU,s Sackler Faculty of Medicine and the ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 According ... Market Research "Ablation Technologies Market (Applications: Cardiovascular, Gynecology, ... Electrical, Ultrasound, Microwave, Cryotherapy) - Global Industry Analysis, ... 2020," the global ablation technologies market was valued ... estimated to reach a market worth USD 10,611 ...
(Date:8/27/2014)... and tested an advanced statistical model to evaluate ... disease as published yesterday in Human Genetics ... gap in current analyses. Complex diseases like cancer ... environmental factors. When many such combinations are studied, ... chance combinations among affected individuals becomes difficult. In ...
(Date:8/27/2014)... August 27, 2014 Nava Beauty Store and ... to all patrons from those seeking luxury care products to ... They carry high end luxurious brands like Valmont and Elemis ... also sells brands like Dermalogica and Bliss to provide easy ... customers. They also offer purely organic skin care products such ...
Breaking Medicine News(10 mins):Health News:Deva Premal & Miten's Mantras For Life Tour Announced 2Health News:Deva Premal & Miten's Mantras For Life Tour Announced 3Health News:'Junk' blood tests may offer life-saving information 2Health News:Global Ablation Technologies Market Expected to Reach USD 10.6 Billion in 2020: Transparency Market Research 2Health News:Global Ablation Technologies Market Expected to Reach USD 10.6 Billion in 2020: Transparency Market Research 3Health News:Global Ablation Technologies Market Expected to Reach USD 10.6 Billion in 2020: Transparency Market Research 4Health News:Global Ablation Technologies Market Expected to Reach USD 10.6 Billion in 2020: Transparency Market Research 5Health News:Dartmouth isolates environmental influences in genome-wide association studies 2Health News:Nava Beauty Store Announce Grand Opening in Great Neck, New York 2
... On May 30, 2008, CareToLive will,take to the ... Madison, Atlanta, Seattle, Dearborn, and Tampa.,Joining us will be ... Live, and the Sarcoma Foundation of America. We are ... protest., 1 in 6 men get prostate cancer. ...
... MED3OOO Group, Inc. (MED3OOO), a,national healthcare management and ... subsidiary of MED3OOO, for billing, marketing, and,business support ... of the South,Carolina Provider Outreach and Education (POE) ... select members that represent key groups,from the provider,s ...
... Bill Gives FDA Regulatory Authority Over Tobacco, ... organization in the country, today announces their,support of ... Control,Act." The legislation gives FDA regulatory authority over ... this important legislation this year.,H.R. 1108 has broad ...
... Research Council (BBSRC) have found a fast and effective way ... the University of Oxford and The Open University, Dr Lynne ... fruit flies that means flies can now be used to ... work published today in the journal Aging Cell, the researchers ...
... The situation for children,continues to worsen in Myanmar ... many more are living in desperate conditions in relief,camps, ... dead bodies, a,UNICEF report stated today., The information ... 10 offices in Myanmar. It details the most urgent ...
... surgery, , , SUNDAY, May 11 (HealthDay News) -- Human spines ... twist, reach and more. , But, in some people, the ... spine takes on an "S" or "C" shape. , This ... million Americans, according to the National Scoliosis Foundation. While it ...
Cached Medicine News:Health News:FDA Says, 'Wait' To Dying Men; Coast-To-Coast Prostate Cancer Demonstrations on May 30th in Protest of FDA Failure to Approve Safe, Effective Immunotherapy 2Health News:FDA Says, 'Wait' To Dying Men; Coast-To-Coast Prostate Cancer Demonstrations on May 30th in Protest of FDA Failure to Approve Safe, Effective Immunotherapy 3Health News:PSA, LLC, a MED3OOO Company, Selected as a Member of the SC Provider Outreach and Education Advisory Group 2Health News:PSA, LLC, a MED3OOO Company, Selected as a Member of the SC Provider Outreach and Education Advisory Group 3Health News:Human aging gene found in flies 2Health News:UNICEF REPORT: Desperate Conditions for Children in Camps Without Clean Water as Cyclone Aftermath Worsens 2Health News:UNICEF REPORT: Desperate Conditions for Children in Camps Without Clean Water as Cyclone Aftermath Worsens 3Health News:UNICEF REPORT: Desperate Conditions for Children in Camps Without Clean Water as Cyclone Aftermath Worsens 4Health News:Scoliosis: An Unnatural Curve 2Health News:Scoliosis: An Unnatural Curve 3
... Volks revolutionary MiniQuad, the DynaView 156 is ... of the retina extending to the ora ... patients. Featuring a minified housing and reduced ... revolutionizes retinopathy of prematurity surgery and is ...
... If you prefer a standard ... the Volk Iridectomy Lens. Its ... view you're used to but ... Volk's exclusive Double Aspheric design ...
... re-designed Super Macula® 2.2 offers extremely high ... fovea, while achieving an exceptionally wide 78° ... excellent choice for critical evaluation of the ... for detailed views of the macula and ...
... The Volk TransEquator is designed for ... diagnosis. Its unique optical design presents a ... an impressive wide-field view of the entire ... superior optics of this lens allows dynamic ...
Medicine Products: